Phase 2 study of effects of lepodisiran on elevated Lp(a) (ALPACA, NCT05565742, Completed)

A study to determine the efficacy and safety of lepodisiran in adults with elevated Lp(a)

Please login or create a FREE account to view this content

Educational Partners and Supporters